Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Matrine or Kanglaite for cancer cachexia
ChiCTR-OPC-17012609Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2017
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of matrine, kanglaite and megestrol in cancer anorexia-cachexia syndrome (CACS) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Quality of life score and Body weight change. Started Sep 2017; status: recruiting.
02
Drugs
matrinekanglaitemegestrol
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on ChiCTR-OPC-17012609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17012609.